IJOHNS  Vol.1 No.2 , August 2012
The Utility of Fine-Needle Aspiration in the Diagnosis and Management of Follicular Thyroid Neoplasms:One Institution’s 10-Year Experience
Abstract: Background: Classical teaching dictates that follicular adenoma (FA) can be distinguished from follicular carcinoma (FC) based on histologic features only. We retrospectively reviewed our institution’s 10-year experience in the use of fine-needle aspiration (FNA) to diagnose follicular thyroid neoplasms. Methods: Patients who had FNA of a thyroid neoplasm from 2000 to 2010 were reviewed. Diagnoses of FA, FC, or follicular neoplasm-not otherwise specified (NOS) were included. Cytopathological results were correlated with surgical pathology. Results: Of 138 patients, 65% underwent surgery. FNA diagnosis for FA had a sensitivity of 50% and specificity of 71%. 25% of patients with an FNA diagnosis of FA were found to have cancer after surgical specimen examination. FNA diagnosis for FC had a sensitivity of 60% and specificity of 94%. Conclusions: FNA has a low sensitivity for diagnosing FA. Surgical pathology remains the gold standard for differentiating follicular carcinoma from adenoma.
Cite this paper: R. Deeb, O. Alassi, S. Sharma, M. Lu and T. Ghanem, "The Utility of Fine-Needle Aspiration in the Diagnosis and Management of Follicular Thyroid Neoplasms:One Institution’s 10-Year Experience," International Journal of Otolaryngology and Head & Neck Surgery, Vol. 1 No. 2, 2012, pp. 18-23. doi: 10.4236/ijohns.2012.12004.

[1]   [1] Z. W. Baloch and V. A. Livolsi, “Follicular-Patterned Lesions of the Thyroid: The Bane of the Pathologist,” American Journal of Clinical Pathology, Vol. 117, No. 1, 2002, pp. 143-150.

[2]   Z. W. Baloch, V. A. LiVolsi, S. L. Asa, et al., “Diagnostic Terminology and Morphologic Criteria for Cytologic Diagnosis of Thyroid Lesions: A Synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference,” Diagnostic Cytopathology, Vol. 36, No. 6, 2008, pp. 425-437. Hdoi:10.1002/dc.20830

[3]   S. R. Kini, J. M. Miller, J. I. Hamburger and M. J. Smith-Purslow, “Cytopathology of Follicular Lesions of the Thyroid Gland,” Diagnostic Cytopathology, Vol. 1, No. 2, 1985, pp. 123-132. Hdoi:10.1002/dc.2840010208

[4]   J. Maruta, H. Hashimoto, Y. Suehisa, et al., “Improving the Diagnostic Accuracy of Thyroid Follicular Neoplasms: Cytological Features in Fine-Needle Aspiration Cytology,” Diagnostic Cytopathology, Vol. 39, No. 1, 2011, pp. 28-34. Hdoi:10.1002/dc.21321

[5]   H. Gharib and J. R. Goellner, “Fine-Needle Aspiration Biopsy of the Thyroid: An Appraisal,” Annals of Internal Medicine, Vol. 118, No. 4, 1993, pp. 282-289.

[6]   K. Suen, “Guidelines of the Papanicolaou Society of Cytopathology for the Examination of Fine-Needle Aspiration Specimens from Thyroid Nodules: The Papanicolaou Society of Cytopathology Task Force on Standards of Practice,” Diagnostic Cytopathology, Vol. 15, No. 1, 1996, pp. 84-89. Hdoi:10.1002/(SICI)1097-0339(199607)15:1<84::AID-DC18>3.0.CO;2-8

[7]   D. S. Cooper, G. M. Doherty, B. R. Haugen, et al., “Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer,” Thyroid, Vol. 16, No. 2, 2006, pp. 109-142. Hdoi:10.1089/thy.2006.16.109

[8]   H. Gharib, E. Papini, R. Valcavi, et al., “American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules,” Endocrine Practice, Vol. 12, No. 1, 2006, pp. 63-102.

[9]   R. T. Schlinkert, J. A. van Heerden, J. R. Goellner, et al., “Factors That Predict Malignant Thyroid Lesions When Fine-Needle Aspiration Is ‘Suspicious for Follicular Neoplasm’,” Mayo Clinic Proceedings, Vol. 72, No. 10, 1997, pp. 913-916. doi:10.1016/S0025-6196(11)63360-0

[10]   R. M. Tuttle, H. Lemar and H. B. Burch, “Clinical Features Associated with an Increased Risk of Thyroid Malignancy in Patients with Follicular Neoplasia by Fine-Needle Aspiration,” Thyroid, Vol. 8, No. 5, 1998, pp. 377-383. Hdoi:10.1089/thy.1998.8.377

[11]   D. S. Tyler, D. J. Winchester, N. P. Caraway, R. C. Hickey and D. B. Evans, “Indeterminate Fine-Needle Aspiration Biopsy of the Thyroid: Identification of Subgroups at High Risk for Invasive Carcinoma,” Surgery, Vol. 116, No. 6, 1994, pp. 1054-1060.

[12]   Z. W. Baloch, S. Fleisher, V. A. LiVolsi and P. K. Gupta, “Diagnosis of ‘follicular neoplasm’: A Gray Zone in Thyroid Fine-Needle Aspiration Cytology,” Diagnostic Cytopathology, Vol. 26, No. 1, 2002, pp. 41-44. Hdoi:10.1002/dc.10043

[13]   M. Alejo, G. Peiro, E. Oliva, X. Matias-Guiu and S. Schr?der, “Leu-M 1 Immunoreactivity in Papillary Carcinomas of the Thyroid Gland; Microcarcinoma, Encapsulated, Conventional and Diffuse Sclerosing Subtypes,” Virchows Archiv, Vol. 419, No. 5, 1991, pp. 447-448. Hdoi:10.1007/BF01605080

[14]   Z. W. Baloch, S. Abraham, S. Roberts and V. A. LiVolsi, “Differential Expression of Cytokeratins in Follicular Variant of Papillary Carcinoma: An Immunohistochemical Study and Its Diagnostic Utility,” Human Pathology, Vol. 30, No. 10, 1999, pp. 1166-1171. Hdoi:10.1016/S0046-8177(99)90033-3

[15]   P. L. Fernandez, M. J. Merino, M. Gomez, et al., “Galectin3 and Laminin Expression in Neoplastic and Non-Neoplastic Thyroid Tissue,” The Journal of Pathology, Vol. 181, No. 1, 1997, pp. 80-86. Hdoi:10.1002/(SICI)1096-9896(199701)181:1<80::AID-PATH699>3.0.CO;2-E

[16]   K. T. Mai, J. C. Ford, H. M. Yazdi, D. G. Perkins and A. S. Commons, “Immunohistochemical Study of Papillary Thyroid Carcinoma and Possible Papillary Thyroid Carcinoma-Related Benign Thyroid Nodules,” PathologyResearch and Practice, Vol. 196, No. 8, 2000, pp. 533-540. Hdoi:10.1016/S0344-0338(00)80025-4

[17]   M. J. Sack, C. Astengo-Osuna, B. T. Lin, H. Battifora and V. A. LiVolsi, “HBME-1 Immunostaining in Thyroid Fine-Needle Aspirations: A Useful Marker in the Diagnosis of Carcinoma,” Modern Pathology, Vol. 10, No. 7, 1997, pp. 668-674.

[18]   K. H. van Hoeven, A. J. Kovatich and M. Miettinen, “Immunocytochemical Evaluation of HBME-1, CA 19-9, and CD-15 (Leu-M1) in Fine-Needle Aspirates of Thyroid Nodules,” Diagnostic Cytopathology, Vol. 18, No. 2, 1998, pp. 93-97. Hdoi:10.1002/(SICI)1097-0339(199802)18:2<93::AID-DC3>3.0.CO;2-U

[19]   C. C. Cheung, B. Carydis, S. Ezzat, Y. C. Bedard and S. L. Asa, “Analysis of Ret/PTC Gene Rearrangements Refines the Fine Needle Aspiration Diagnosis of Thyroid Cancer,” The Journal of Clinical Endocrinology & Metabolism, Vol. 86, No. 5, 2001, pp. 2187-2190. Hdoi:10.1210/jc.86.5.2187

[20]   Y. Cohen, E. Rosenbaum, D. P. Clark, et al., “Mutational Analysis of BRAF in Fine Needle Aspiration Biopsies of the Thyroid: A Potential Application for the Preoperative Assessment of Thyroid Nodules,” Clinical Cancer Research, Vol. 10, 2004, pp. 2761-2765. Hdoi:10.1158/1078-0432.CCR-03-0273

[21]   L. Jin, T. J. Sebo, N. Nakamura, et al., “BRAF Mutation Analysis in Fine Needle Aspiration (FNA) Cytology of the Thyroid,” Diagnostic Molecular Pathology, Vol. 15, No. 3, 2006, pp. 136-143. Hdoi:10.1097/01.pdm.0000213461.53021.84

[22]   Z. Kucukodaci, E. Akar, A. Haholu and H. Baloglu, “A Valuable Adjunct to FNA Diagnosis of Papillary Thyroid Carcinoma: In-House PCR Assay for BRAF T1799A (V600E),” Diagnostic Cytopathology, Vol. 39, No. 6, 2011, pp. 424-427. Hdoi:10.1002/dc.21406

[23]   Y. E. Nikiforov, D. L. Steward and T. M. RobinsonSmith, et al., “Molecular Testing for Mutations in Improving the Fine-Needle Aspiration Diagnosis of Thyroid Nodules,” The Journal of Clinical Endocrinology & Metabolism, Vol. 94, No. 6, 2009, pp. 2092-2098. Hdoi:10.1210/jc.2009-0247

[24]   G. Tallini and G. Brandao, “Assessment of RET/PTC Oncogene Activation in Thyroid Nodules Utilizing Laser Microdissection Followed by Nested RT-PCR,” Methods in Molecular Biology, Vol. 293, 2005, pp. 103-111.

[25]   E. S. Cibas and S. Z. Ali, “The Bethesda System for Reporting Thyroid Cytopathology,” American Journal of Clinical Pathology, Vol. 132, 2009, pp. 658-665. Hdoi:10.1309/AJCPPHLWMI3JV4LA